glp-1 shortages National Hispanic Medical Association | After compounded drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Ends Compounding of GLP-1

Punitive damages may be available in cases where the evidence shows that a company concealed known risks or failed to update its warning labels in a timely manner

A weekly injection may be better if you struggle to remember daily medications

For 68 weeks, participants in the experiment were given semaglutide or a placebo in addition to a lifestyle intervention

Pederson RA, Satkunaraja M, McIntosh CH, Scrocchi LA, Flamenz D, Schuit F, Drucker DJ, Wheeler MB

An AI breakthrough from MIT reveals a system that can forecast cardiovascular disease risk with a single chest X-ray

doi: 10.1007/s00018-020-03514-x 134 XiM.LiJ.HaoG.AnX.SongY.WeiH.et al